Alira Health and HTAi Collaborate to Develop a Multi-Stakeholder Value Assessment Framework for Robotic-Assisted Surgery & Digital Health

Alira Health, a global healthcare consulting and technology firm with expertise in Health Technology Assessment (HTA) methodology, will coordinate the discussion and consensus of evidence-based guidance on HTA for Robotic-Assisted Surgery (RAS) and Digital Health Technologies.

This multi-stakeholder Value Assessment Framework will provide guidance on how to overcome challenges in determining the cost-effectiveness of robotic-assisted surgery from the perspectives of patients, physicians, and payers.

The framework, designed in collaboration with the HTAi Medical Device Interest Group, is technology and company agnostic. Key areas of guidance will include:

  • best practices in assessing the value of robotic-assisted surgery at both the national and hospital level;
  • how to support the implementation of RAS and Digital Health programs globally;
  • how to ensure the clinician and patient perspectives are included in the quantification of value.

The following areas of consensus will be sought from a panel of leading robotic-assisted surgeons, leading health economists, and policymakers:

  • Clinical Challenges
    • Evidence type and quality (RCT vs RWE)
    • Physician and patient-reported outcomes
    • Physician learning curve
  • Economic Challenges
    • Appropriate Time Horizon for evaluation
    • Challenges of a high upfront capital investment
    • Organizational impact on surgical procedures
  • Digital Challenges
    • Evaluation of an increasingly digitally-enabled RAS ecosystem
    • Overcoming the rapid evolution of digital solutions
Published on:
March 22, 2022
"The guidance will be aimed at HTA agencies globally and will allow them to better assess the value of robotic surgical and digital health systems. We are pleased to be overseeing the operation of such a crucial project and contributing to the development of the consensus document and scientific publication with the recommendations for HTA agencies."
Richard Charter Vice President MedTech Market Access - Europe & Asia Pacific at Alira Health

About Alira Health

Alira Health is an international patient-centric and technology-enabled advisory firm whose mission is to humanize healthcare. We work with healthcare and life sciences organizations looking for support across their entire solutions lifecycle. From development to medical care, we complement our clients’ expertise with a full spectrum of services including research and clinical development solutions, technology-powered consulting, and real-world evidence.

Our integrated and multidisciplinary team of over 500 scientists, strategists, economists, clinicians, and biostatisticians collaborate across our North American, European, and Asian offices and advise 80% of the top 50% of MedTech companies and 75% of the top 50% of Pharma companies.

About HTAi

Health Technology Assessment international (HTAi) is the global, non-profit, scientific, and professional society for all those who produce, use or encounter health technology assessment (HTA). The society represents 82 organizations and over 2,500 individual members from 65 countries around the world.

Related news

Multimedia May 10, 2022
VacciTalks: Behind the Scenes: Challenging Race of Vaccine Development
Join the 2nd episode of VacciTalks where together with vaccine expert Roberto Camerini we will peek behind the scenes of vaccine development and get an insider look at the difficulties,(...)
Market Access
Events May 9, 2022
7e Journée start-up innovantes du dispositif médical
Clinical Digital Health Market Access MedTech Research & Development
Multimedia April 28, 2022
Alira Health’s Transformation Talks: Real-World Data to Support HTAs in Europe
Learn more about RWD as a support in HTAs and its direct impact on HTAs budgets, results, and even patient outcomes by listening to this episode of Transformation Talks.
Clinical Market Access RWE
Publications April 20, 2022
White Paper: Next Generation Therapies: Access, Pricing and Ethical Issues in Perspective
In this white paper, we will explore wide range of new therapies we term “Next Generation Therapies” and challenges related to them.
Market Access
Publications March 31, 2022
Real-World Evidence: Five Facts You Need to Know
Learn more about RWD and its future challenges for Europe, we asked Romain Finas, Vice President of Real-World Evidence (RWE) at Alira Health, to share five facts that you need to know about it.
Market Access RWE
Publications March 25, 2022
Early Access Programs: Keys to Success
Discover Alira Health’s top five recommendations to building a successful Early Access Programs (EAP). 
Market Access
News March 22, 2022
Alira Health and HTAi Collaborate to Develop a Multi-Stakeholder Value Assessment Framework for Robotic-Assisted Surgery & Digital Health
Learn more about the new evidence-based guidance on HTA for Robotic-Assisted Surgery and Digital Health Technologies. 
Market Access
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.